Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Follicular × High-Intensity Interval Training × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 16 Polycystic Ovary Syndrome 7 Prostatic Neoplasms 6 Neoplasms 5 Breast Neoplasms 5 Colorectal Neoplasms 4 Lung Neoplasms 2 Insulin Resistance 2 Fatigue 2 Cardiotoxicity 2 Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Primary Dysautonomias 1 Pediatric Brain Tumor 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lupus Erythematosus, Systemic 1 Inflammation 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Diabetes Mellitus, Type 1 1 Chemotherapy-Related Cognitive Impairment 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1 Cachexia 1 Brain Neoplasms 1

Interventions

Rituximab 257 Cyclophosphamide 214 fludarabine phosphate 93 Peripheral Blood Stem Cell Transplantation 93 Filgrastim 81 Etoposide 75 Radiotherapy 74 Lenalidomide 73 Vincristine 71 Prednisone 71 Doxorubicin 57 Mycophenolic Acid 56 Bendamustine Hydrochloride 55 Whole-Body Irradiation 53 Cyclosporine 51 Melphalan 47 fludarabine 46 obinutuzumab 45 Tacrolimus 43 Cytarabine 42 Busulfan 41 Methotrexate 38 Antilymphocyte Serum 34 Methylprednisolone 32 Bortezomib 31 Carmustine 30 ibritumomab tiuxetan 28 Dexamethasone 28 sargramostim 27 ibrutinib 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04902092 2023-10-23

BEAT

Monash University

Phase NA Completed

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡